Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» non-small cell lung cancer
non-small cell lung cancer
Oncothyreon Announces Presentation of PX-866 Clinical Data at American Association of Clinical Oncology Annual Meeting
Yahoo/PR NewsWire
Sun, 06/3/12 - 11:06 am
PX-866
Oncothyreon
non-small cell lung cancer
squamous cell cancer
Endocyte Scores With Merck Partnership
Seeking Alpha
Sun, 04/22/12 - 12:13 pm
Endocyte
Merck
vintafolide
ovarian cancer
non-small cell lung cancer
Peregrine's cancer drug data disappoints; shares plunge
Reuters
Fri, 03/9/12 - 04:21 pm
Peregrine Pharmaceuticals
bavituximab
non-small cell lung cancer
Oxigene Headed Back Down On Disappointing Zybrestat Results
Seeking Alpha
Fri, 11/4/11 - 09:20 am
Zybrestat
Oxigene
non-small cell lung cancer
Merck KGaA, Ono Pharma Collaborate
Yahoo/Zacks
Sat, 10/15/11 - 11:34 am
Merck KGaA
Ono Pharmaceutical
ONO-4641
multiple sclerosis
Stimuvax
non-small cell lung cancer
ADVENTRX Announces Results of FDA Meeting to Discuss Exelbine NDA
Yahoo/PR NewsWire
Sat, 10/1/11 - 12:48 pm
Adventrx
Exelbine
non-small cell lung cancer
Qiagen Partners with Pfizer
Yahoo/Zacks.com
Wed, 08/17/11 - 12:05 pm
Qiagen
Pfizer
non-small cell lung cancer
Oncothyreon: Possible Pharma Blockbuster
Seeking Alpha
Wed, 07/20/11 - 12:53 pm
Oncothyreon
Stimuvax
non-small cell lung cancer
New Study Released Today Showed Patients With Deadly Form of Lung Cancer Lived Longer Without Disease Worsening
Yahoo/PR NewsWire
Sun, 06/5/11 - 10:41 am
Eli Lilly
Alimta
non-small cell lung cancer
Final Phase III Data from Study CA031 of ABRAXANE® in Combination with Carboplatin in Patients with Non-Small Cell Lung Cancer Presented at ASCO
Yahoo/BusinessWire
Sun, 06/5/11 - 10:26 am
Abraxane
Celgene
carboplatin
non-small cell lung cancer
OXiGENE Reports Encouraging Data From Phase 2 Trial of ZYBRESTAT(TM) in Non-small Cell Lung Cancer
Yahoo/Globe NewsWire
Sun, 06/5/11 - 10:07 am
Oxigene
Zybrestat
non-small cell lung cancer
MethylGene Announces $34.5 Million Private Placement
newsystocks
Thu, 03/24/11 - 04:35 pm
MethylGene
MGCD265
non-small cell lung cancer
Pipeline Setback for Regeneron
Yahoo/Zacks.com
Wed, 03/16/11 - 09:50 pm
Regeneron
non-small cell lung cancer
Aflibercept
Sanofi
AdventRx: Safe Biotech With Upcoming Catalysts That May Boost It More
Seeking Alpha
Tue, 02/15/11 - 11:55 am
Adventrx
Exelbine
non-small cell lung cancer
Oncothyreon announces that Merck Serono is resuming the Stimuvax clinical program in lung cancer
Yahoo/PR NewsWire
Thu, 06/17/10 - 09:19 am
Oncothyreon
Merck Serono
Stimuvax
non-small cell lung cancer
Researchers Report Treatment Headway Against Lung Cancer
BusinessWeek
Sun, 06/6/10 - 11:52 am
crizotinib
non-small cell lung cancer
Pfizer
OXiGENE Reports Encouraging Safety and Efficacy Data from Ongoing Phase 2 Trial of ZYBRESTAT in Non-Small Cell Lung Cancer at the 2010 ASCO Annual Meeting
Yahoo/Globe NewsWire
Sun, 06/6/10 - 10:53 am
Oxigene
non-small cell lung cancer
Zybrestat
Results of Phase 3 ABRAXANE® Combination Trial In First-Line Non-Small Cell Lung Cancer Show 31 Percent Improvement In Response Rate Compared With Taxol Combination
BusinessWire
Sat, 06/5/10 - 12:34 pm
Abraxane
Taxol
carboplatin
companies
non-small cell lung cancer
Exelixis Presents Positive Data
Yahoo/Zacks
Sat, 05/22/10 - 09:38 am
XL184
Bristol-Myers Squibb
glioblastoma
brain cancer
melanoma
non-small cell lung cancer
small cell lung cancer
hepatocellular carcinoma
pancreatic
gastric
prostate
ovarian
breast cancer
Hope Grows for FDA Approval of Adventrix's Chemo Drug
Seeking Alpha
Sun, 05/2/10 - 11:15 am
Adventrx
ANX-53
vinorelbine. Navelbine
non-small cell lung cancer
Pages
« first
‹ previous
…
14
15
16
17
18
19
20
21
22
next ›
last »